Quick Listen: Scrip’s Five Must-Know Things
Join us for a brief audio tour around key developments in the global biopharma industry over the past week, in this podcast version of Scrip's Five Must-Know Things.
Join us in our regular podcast covering major industry events over the past week, in this audio version of Scrip's Five Must-Know Things, this time for the business week ended 13 November 2020.
COVID-19 vaccines dominate developments this time, along with a failed deal in idiopathic pulmonary fibrosis and yet another setback in Alzheimer's disease.
These and other Informa Pharma Intelligence podcasts are available on SoundCloud, Apple Podcasts and TuneIn, and also as a skill on Alexa smart speakers.
Articles mentioned in this episode:
(Also see "Pfizer And BioNTech Claim COVID-19 Vaccine Success" - Scrip, 9 Nov, 2020.)
(Also see "COVID-19 Vaccine Results A Breakthrough Moment For BioNTech" - Scrip, 11 Nov, 2020.)
(Also see "Sanofi CEO Takes Not-So-Slow And Steady Approach To COVID-19 Vaccines" - Scrip, 10 Nov, 2020.)
(Also see "Boehringer, Bridge IPF Deal Collapses On Toxicity Concerns" - Scrip, 11 Nov, 2020.)
(Also see "Aducanumab Panel Pushes Back On Rosy FDA Outlook, Could Derail A Swift Approval" - Scrip, 7 Nov, 2020.)
Details of the FDA/CMS summit on 7-9 December as mentioned in the podcast can be found here.